Latest Financial Results
Fiscal Year Ended Dec 31, 2019
Stay informed and receive company updates straight to your inboxSign up today
HJLI specializes in developing and manufacturing bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two product candidates: the porcine tissue based VenoValve®, which is intended to be surgically implanted in the deep venous system of the leg to treat Chronic Venue Insufficiency and the CoreoGraft®, a bovine tissue based off the shelf conduit intended to be used for coronary artery bypass surgery.
Investor Contact Information
Hancock Jaffe Laboratories, Inc.
Irvine, CA 92618
V Stock Transfer LLC